{
    "eid": "2-s2.0-85102212634",
    "title": "Drug-drug Interactions among Thai Transgender Women Living with Human Immunodeficiency Undergoing Feminizing Hormone Therapy and Antiretroviral Therapy: The iFACT Study",
    "cover-date": "2021-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "antiretroviral therapy",
        "drug-drug interactions",
        "feminizing hormone",
        "transgender women"
    ],
    "authors": [
        "Akarin Hiransuthikul",
        "Linrada Himmad",
        "Stephen J. Kerr",
        "Rena Janamnuaysook",
        "Theera Dalodom",
        "Kannapat Phanjaroen",
        "Tippawan Pankam",
        "Jiratchaya Kongkapan",
        "Stephen Mills",
        "Ravipa Vannakit",
        "Praphan Phanuphak",
        "Nittaya Phanuphak"
    ],
    "citedby-count": 9,
    "ref-count": 33,
    "ref-list": [
        "Worldwide burden of HIV in transgender women: a systematic review and meta-analysis",
        "Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review",
        "Health and health care among maleto-female transgender persons who are HIV positive",
        "Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices",
        "Transgender women living with HIV frequently take antiretroviral therapy and/or feminizing hormone therapy differently than prescribed due to drug-drug interaction concerns",
        "The development of sex reassignment surgery in Thailand: a social perspective",
        "Exploration of functional health, mental well-being and cross-sex hormone use in a sample of Thai male-to-female transgendered persons (kathoeys)",
        "Antiretroviral therapy adherence among transgender women living with HIV",
        "Characteristics of transgender women living with HIV receiving medical care in the United States",
        "Medication adherence among transgender women living with HIV",
        "Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus",
        "Drugdrug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study",
        "Treating a transgender patient: overview of the guidelines",
        "Drug interactions between hormonal contraceptives and antiretrovirals",
        "UDP-glucuronosyltransferases and clinical drug-drug interactions",
        "The effect of efavirenz on estradiol metabolism in transgender women",
        "Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline",
        "Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV",
        "Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis",
        "Nevirapine-based antiretroviral therapy does not reduce oral contraceptive effectiveness",
        "Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels when coadministered with combined oral contraceptives",
        "Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIVpositive women",
        "The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women",
        "Integrated gender affirmative hormone treatment services improve access to and retention in HIV testing, syphilis testing and pre-exposure prophylaxis (PrEP) service uptake among transgender women in Thailand",
        "The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offenders"
    ],
    "affiliation": [
        {
            "affiliation-city": "Durham",
            "@id": "60120612",
            "affilname": "FHI 360",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60120612",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Atlanta",
            "@id": "60021658",
            "affilname": "Centers for Disease Control and Prevention",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021658",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Washington, D.C.",
            "@id": "60008275",
            "affilname": "United States Agency for International Development",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008275",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "HIV Netherlands Australia Thailand Research Collaboration",
        "Narukjaporn Thammajaruk",
        "United States Agency for International Development",
        "University of North Carolina",
        "US President s Emergency Plan for AIDS Relief"
    ]
}